Ignite Creation Date:
2025-12-24 @ 3:38 PM
Ignite Modification Date:
2025-12-29 @ 1:21 AM
Study NCT ID:
NCT02890992
Status:
COMPLETED
Last Update Posted:
2019-09-06
First Post:
2016-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-15
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-22
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-31
First Submit QC Date:
None
Study First Post Date:
2016-09-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-08-15
Results First Submit QC Date:
None
Results First Post Date:
2019-09-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-15
Last Update Post Date:
2019-09-06
Last Update Post Date Type:
ACTUAL